• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Assessing the Significance of BRCA1 and BRCA2 Mutations in Pancreatic Cancer.

作者信息

Carnevale Julia, Ashworth Alan

机构信息

University of California, San Francisco, Helen Diller Comprehensive Cancer Center, San Francisco, CA.

University of California, San Francisco, Helen Diller Comprehensive Cancer Center, San Francisco, CA

出版信息

J Clin Oncol. 2015 Oct 1;33(28):3080-1. doi: 10.1200/JCO.2015.61.6961. Epub 2015 May 18.

DOI:10.1200/JCO.2015.61.6961
PMID:25987697
Abstract
摘要

相似文献

1
Assessing the Significance of BRCA1 and BRCA2 Mutations in Pancreatic Cancer.评估BRCA1和BRCA2突变在胰腺癌中的意义。
J Clin Oncol. 2015 Oct 1;33(28):3080-1. doi: 10.1200/JCO.2015.61.6961. Epub 2015 May 18.
2
BRCA-mutant pancreatic ductal adenocarcinoma.BRCA 突变型胰腺导管腺癌。
Br J Cancer. 2021 Nov;125(10):1321-1332. doi: 10.1038/s41416-021-01469-9. Epub 2021 Jul 14.
3
Outcome of Pancreatic Cancer Surveillance Among High-Risk Individuals Tested for Germline Mutations in and .种系基因突变 和 检测的高危个体的胰腺癌监测结果
Cancer Prev Res (Phila). 2019 Sep;12(9):599-608. doi: 10.1158/1940-6207.CAPR-18-0272. Epub 2019 Jul 23.
4
BRCA-associated pancreatico-biliary neoplasms: Four cases illustrating the emerging clinical impact of genotyping.BRCA相关的胰胆管肿瘤：4例病例说明基因分型新出现的临床影响。
Acta Oncol. 2016;55(3):377-81. doi: 10.3109/0284186X.2015.1044023. Epub 2015 May 23.
5
Germline BRCA Mutations in a Large Clinic-Based Cohort of Patients With Pancreatic Adenocarcinoma.胚系 BRCA 突变在大型基于临床的胰腺导管腺癌患者队列中的研究。
J Clin Oncol. 2015 Oct 1;33(28):3124-9. doi: 10.1200/JCO.2014.59.7401. Epub 2015 May 4.
6
Risk of pancreatic ductal adenocarcinoma associated with carriage of BRCA1 and/or BRCA2 mutation: A systematic review and meta-analysis.BRCA1 和/或 BRCA2 基因突变携带者患胰腺导管腺癌的风险：系统评价和荟萃分析。
J Surg Oncol. 2022 Nov;126(6):1028-1037. doi: 10.1002/jso.26994. Epub 2022 Jun 30.
7
Statewide Retrospective Review of Familial Pancreatic Cancer in Delaware, and Frequency of Genetic Mutations in Pancreatic Cancer Kindreds.特拉华州家族性胰腺癌的全州回顾性研究以及胰腺癌家族中基因突变的频率。
Ann Surg Oncol. 2016 May;23(5):1729-35. doi: 10.1245/s10434-015-5026-x. Epub 2016 Jan 4.
8
AGA Clinical Practice Update on Colorectal and Pancreatic Cancer Risk and Screening in BRCA1 and BRCA2 Carriers: Commentary.美国胃肠病学会关于BRCA1和BRCA2基因携带者结直肠癌和胰腺癌风险及筛查的临床实践更新：评论
Gastroenterology. 2020 Aug;159(2):760-764. doi: 10.1053/j.gastro.2020.03.086. Epub 2020 Apr 23.
9
BRCA and pancreatic cancer.乳腺癌易感基因与胰腺癌
JOP. 2013 Jul 10;14(4):325-8. doi: 10.6092/1590-8577/1652.
10
Inherited predisposition to pancreatic adenocarcinoma: role of family history and germ-line p16, BRCA1, and BRCA2 mutations.胰腺癌的遗传易感性：家族史及种系p16、BRCA1和BRCA2基因突变的作用
Cancer Res. 2000 Jan 15;60(2):409-16.

引用本文的文献

1
Dual epigenetic changes in diabetes mellitus-associated pancreatic ductal adenocarcinoma correlate with downregulation of E-cadherin and worsened prognosis.糖尿病相关胰腺导管腺癌中双重表观遗传学改变与 E-钙黏蛋白下调及预后不良相关。
J Pathol Clin Res. 2023 Sep;9(5):354-366. doi: 10.1002/cjp2.326. Epub 2023 May 28.
2
Evolutionary Trajectories of Primary and Metastatic Pancreatic Neuroendocrine Tumors Based on Genomic Variations.基于基因组变异的胰腺神经内分泌肿瘤原发灶和转移灶的演进轨迹。
Genes (Basel). 2022 Sep 4;13(9):1588. doi: 10.3390/genes13091588.
3
Altering the response to radiation: radiosensitizers and targeted therapies in pancreatic ductal adenocarcinoma: preclinical and emerging clinical evidence.
改变对辐射的反应：胰腺导管腺癌中的放射增敏剂和靶向治疗：临床前及新出现的临床证据
Ann Pancreat Cancer. 2018 Aug;1(8). doi: 10.21037/apc.2018.08.02. Epub 2018 Aug 31.
4
Poly(ADP-Ribose)Polymerase (PARP) Inhibitors and Radiation Therapy.聚（ADP - 核糖）聚合酶（PARP）抑制剂与放射治疗
Front Pharmacol. 2020 Mar 3;11:170. doi: 10.3389/fphar.2020.00170. eCollection 2020.
5
Poly(ADP-Ribose) Polymerase Inhibitors in Pancreatic Cancer: A New Treatment Paradigms and Future Implications.聚（ADP - 核糖）聚合酶抑制剂在胰腺癌中的应用：新的治疗模式及未来意义
Cancers (Basel). 2019 Dec 9;11(12):1980. doi: 10.3390/cancers11121980.
6
Abdominal Imaging of Pancreatic Cysts and Cyst-Associated Pancreatic Cancer in BRCA1/2 Mutation Carriers: A Retrospective Cross-Sectional Study.BRCA1/2 基因突变携带者的胰腺囊肿和囊肿相关胰腺癌的腹部影像学表现：一项回顾性横断面研究。
J Am Coll Surg. 2020 Jan;230(1):53-63.e1. doi: 10.1016/j.jamcollsurg.2019.09.019. Epub 2019 Oct 28.
7
Tumor-stromal crosstalk in pancreatic cancer and tissue fibrosis.胰腺癌中的肿瘤-基质相互作用与组织纤维化。
Mol Cancer. 2019 Jan 21;18(1):14. doi: 10.1186/s12943-018-0927-5.
8
PARPs in genome stability and signal transduction: implications for cancer therapy.聚腺苷二磷酸核糖聚合酶在基因组稳定性和信号转导中的作用：对癌症治疗的影响。
Biochem Soc Trans. 2018 Dec 17;46(6):1681-1695. doi: 10.1042/BST20180418. Epub 2018 Nov 12.
9
Cardiovascular Concerns in BRCA1 and BRCA2 Mutation Carriers.携带BRCA1和BRCA2基因突变者的心血管问题
Curr Treat Options Cardiovasc Med. 2018 Mar 1;20(2):18. doi: 10.1007/s11936-018-0609-z.
10
Germline mutations in pancreatic cancer and potential new therapeutic options.胰腺癌中的种系突变及潜在的新治疗选择。
Oncotarget. 2017 Apr 20;8(42):73240-73257. doi: 10.18632/oncotarget.17291. eCollection 2017 Sep 22.